Recent developments in the use of nanoparticles for treatment of biofilms
Open accessThe DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Abstract
Chronic infections have posed a tremendous burden on health care systems worldwide. Approximately 60% of chronic infections are estimated to be related to biofilms, in large part due to the extraordinary antibiotic resistance of biofilm bacteria. Nanoparticle (NP)-based therapies are viable approaches to treat biofilm-associated infections due to NPs’ unique chemical and physical properties, granted by their high surface area to volume ratio. The mechanism underlying the anti-biofilm activity of various types of NPs is actively under investigation. Simply comparing biofilm disruption or reduction rates is not adequate to describe the effectiveness of NPs; many other factors need to be taken into account, such as the NP type, bacterial strain, concentration of NPs, quantification methods, and the biofilm culture environment. This review focuses on recent research on the creation, characterization, and evaluation of NPs for the prevention or treatment of biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The bactericidal property of TiO 2 NPs depends on their size, stability, and concentration added to the growth medium, which provides greater retention time for bacterium NP interaction, allowing them to interact closely with microbial membranes [23,24].”
From Antibacterial Activity of TiO2 Nanoparticles Prepared by One-Step Laser Ablation in Liquid (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“Nanoparticles can prevent, disrupt and inhibit or disperse bacteria from biofilm infections 30 (Fig. 4c).”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“This difference in antibiotic tolerance explains why patients with biofilm infections tend to suffer from chronic complications [1, 2, 13].”
BackgroundFlemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
Lu, A., Salabas, E. L., & Schüth, F. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200602866 · Cited by 6,777 · cited 1×
“However, synthesizing NPs with a uniform size remains a challenge using the co-precipitation method because the size distribution can be affected by a variety of parameters including temperature, pH, salts used, and concentrations [99].”
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771 · cited 1×
“They have the potential to facilitate magnetic resonance imaging (MRI), targeted drug delivery, and hyperthermia-based therapies [96].”
BackgroundSondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986 · cited 1×
“Silver NPs are also known to be capable of binding and penetrating the bacterial cell wall, thus increasing cell wall permeability and cell death [93, 94].”
BackgroundEndothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074 · cited 1×
“NO is an endogenous free radical and is involved in several biological processes [134].”
BackgroundAntimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918 · cited 3×
“It is also reported that the ROS generated on the surface of silver NPs can interact with cell membrane lipids, leading to the disruption of cell membrane functions [91].”
BackgroundMethodDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Since the success of the first liposomal pharmaceutical product, Doxil®, approved by the Food and Drug Administration (FDA) in 1995 [19], NPs have been studied extensively as carriers for drug delivery, imaging contrast agents for diagnosis, and pharmaceutical agents for therapy.”
BackgroundDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Research works printed but not linked: 149
- [3] Abidi SH, Sherwani SK, Siddiqui TR, Bashir A, Kazmi SU. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol. 2013, 13, 57.10.1186/1471-2415-13-57Search in Google Scholar PubMed PubMed Central · doi:10.1186/1471-2415-13-57search
- [40] Subbiahdoss G, Sharifi S, Grijpma DW, Laurent S, van der Mei HC, Mahmoudi M, Busscher HJ. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater. 2012, 8, 2047–2055.10.1016/j.actbio.2012.03.002Search in Google Scholar PubMed · doi:10.1016/j.actbio.2012.03.002search
- [22] Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994, 263, 1600–1603.10.1126/science.8128245Search in Google Scholar PubMed · doi:10.1126/science.8128245search
- [84] Berney M, Hammes F, Bosshard F, Weilenmann HU, Egli T. Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry. Appl. Environ. Microbiol. 2007, 73, 3283–3290.10.1128/AEM.02750-06Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.02750-06search
- [23] d’Angelo I, Casciaro B, Miro A, Quaglia F, Mangoni ML, Ungaro F. Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide. Colloids Surf. B Biointerfaces. 2015, 135, 717–725.10.1016/j.colsurfb.2015.08.027Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2015.08.027search
- [26] Radovic-Moreno A F, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012, 6, 4279–4287.10.1021/nn3008383Search in Google Scholar PubMed PubMed Central · doi:10.1021/nn3008383search
- [17] Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 2014, 14, 742–750.10.1016/S1473-3099(14)70780-7Search in Google Scholar PubMed · doi:10.1016/s1473-3099(14)70780-7search
- [38] Cheow WS, Chang MW, Hadinoto K. The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf. Physicochem. Eng. Asp. 2011, 389, 158–165.10.1016/j.colsurfa.2011.08.035Search in Google Scholar · doi:10.1016/j.colsurfa.2011.08.035search
- [51] Chorell E, Bengtsson C, Sainte-Luce Banchelin T, Das P, Uvell H, Sinha AK, Pinkner JS, Hultgren SJ, Almqvist F. Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity. Eur. J. Med. Chem. 2011, 46, 1103–1116.10.1016/j.ejmech.2011.01.025Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.ejmech.2011.01.025search
- [1] Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284, 1318–1322.10.1126/science.284.5418.1318Search in Google Scholar PubMed · doi:10.1126/science.284.5418.1318search
- [6] Santos APA, Watanabe E, de Andrade D. Biofilm on artificial pacemaker: fiction or reality? Arq. Bras. Cardiol. 2011, 97, e113–e120.10.1590/S0066-782X2011001400018Search in Google Scholar PubMed · doi:10.1590/s0066-782x2011001400018search
- [21] Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R. The pharmacodynamics of aminoglycosides. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 1998, 27, 23–27.10.1086/514620Search in Google Scholar PubMed · doi:10.1086/514620search
- [16] Ray PC, Khan SA, Singh AK, Senapati D, Fan Z. Nanomaterials for targeted detection and photothermal killing of bacteria. Chem. Soc. Rev. 2012, 41, 3193.10.1039/c2cs15340hSearch in Google Scholar PubMed · doi:10.1039/c2cs15340hsearch
- [15] Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 2010, 8, 260–271.10.1038/nrmicro2319Search in Google Scholar PubMed · doi:10.1038/nrmicro2319search
- [41] Taheri S, Baier G, Majewski P, Barton M, Förch R, Landfester K, Vasilev K. Synthesis and surface immobilization of antibacterial hybrid silver-poly(l-lactide) nanoparticles. Nanotechnology. 2014, 25, 305102.10.1088/0957-4484/25/30/305102Search in Google Scholar PubMed · doi:10.1088/0957-4484/25/30/305102search
- [36] Hua X, Tan S, Bandara HMHN, Fu Y, Liu S, Smyth HDC. Externally controlled triggered-release of drug from PLGA micro and nanoparticles. PLoS One 2014, 9, e114271.10.1371/journal.pone.0114271Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0114271search
- [44] Durmus NG, Taylor EN, Kummer KM, Webster TJ. Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites. Adv. Mater. 2013, 25, 5706–5713.10.1002/adma.201302627Search in Google Scholar PubMed · doi:10.1002/adma.201302627search
- [134] Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 1987, 84, 9265–9269.10.1073/pnas.84.24.9265Search in Google Scholar PubMed PubMed Central · doi:10.1073/pnas.84.24.9265search
- [42] Shrestha A, Hamblin MR, Kishen A. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen. Nanomedicine Nanotechnol. Biol. Med. 2014, 10, 491–501.10.1016/j.nano.2013.10.010Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.nano.2013.10.010search
- [93] Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 2006, 22, 9322–9328.10.1021/la060661vSearch in Google Scholar PubMed · doi:10.1021/la060661vsearch
- [5] Høiby N, Ciofu O, Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 2010, 5, 1663–1674.10.2217/fmb.10.125Search in Google Scholar PubMed · doi:10.2217/fmb.10.125search
- [19] Barenholz Y. Doxil®–the first FDA-approved nano-drug: lessons learned. J. Control. Release Off. J. Control. Release Soc. 2012, 160, 117–134.10.1016/j.jconrel.2012.03.020Search in Google Scholar · doi:10.1016/j.jconrel.2012.03.020search
- [30] Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int. J. Nanomedicine 2012, 7, 1805–1818.10.2147/IJN.S28077Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s28077search
- [9] Tran PL, Lowry N, Campbell T, Reid TW, Webster DR, Tobin E, Aslani A, Mosley T, Dertien J, Colmer-Hamood JA, Hamood AN. An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo. Antimicrob. Agents Chemother. 2012, 56, 972–978.10.1128/AAC.05680-11Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.05680-11search
- [71] Parsek MR, Greenberg EP. Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol. 2005, 13, 27–33.10.1016/j.tim.2004.11.007Search in Google Scholar PubMed · doi:10.1016/j.tim.2004.11.007search
- [4] Donlan RM. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7, 277–281.10.3201/eid0702.010226Search in Google Scholar PubMed PubMed Central · doi:10.3201/eid0702.010226search
- [55] Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiol. Read. Engl. 1998, 144(Pt 11), 3039–3047.10.1099/00221287-144-11-3039Search in Google Scholar PubMed · doi:10.1099/00221287-144-11-3039search
- [45] Salunke GR, Ghosh S, Santosh Kumar RJ, Khade S, Vashisth P, Kale T, Chopade S, Pruthi V, Kundu G, Bellare JR, Chopade BA. Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control. Int. J. Nanomedicine 2014, 9, 2635–2653.10.2147/IJN.S59834Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s59834search
- [82] Sun L, Zhang C, Li P. Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J. Agric. Food Chem. 2012, 60, 6150–6156.10.1021/jf3010405Search in Google Scholar PubMed · doi:10.1021/jf3010405search
- [104] Masadeh MM, Karasneh GA, Al-Akhras MA, Albiss BA, Aljarah KM, Al-Azzam SI, Alzoubi KH. Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria. Cytotechnology 2015, 67, 427–435.10.1007/s10616-014-9701-8Search in Google Scholar PubMed PubMed Central · doi:10.1007/s10616-014-9701-8search
- [143] Zhang W, Zhang YH, Ji JH, Zhao J, Yan Q, Chu PK. Antimicrobial properties of copper plasma-modified polyethylene. Polymer 2006, 47, 7441–7445.10.1016/j.polymer.2006.08.057Search in Google Scholar · doi:10.1016/j.polymer.2006.08.057search
- [31] Palanisamy NK, Ferina N, Amirulhusni AN, Mohd-Zain Z, Hussaini J, Ping LJ, Durairaj R. Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J. Nanobiotechnology 2014, 12, 2.10.1186/1477-3155-12-2Search in Google Scholar PubMed PubMed Central · doi:10.1186/1477-3155-12-2search
- [78] Thukkaram M, Sitaram S., Kannaiyan SK, Subbiahdoss G. Antibacterial efficacy of iron-oxide nanoparticles against biofilms on different biomaterial surfaces. Int. J. Biomater. 2014, 2014, 716080.10.1155/2014/716080Search in Google Scholar PubMed PubMed Central · doi:10.1155/2014/716080search
- [63] Taylor PK, Yeung ATY, Hancock REW. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J. Biotechnol. 2014, 191, 121–130.10.1016/j.jbiotec.2014.09.003Search in Google Scholar PubMed · doi:10.1016/j.jbiotec.2014.09.003search
- [43] Taylor EN, Kummer KM, Durmus NG, Leuba K, Tarquinio KM, Webster TJ. Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small 2012, 8, 3016–3027.10.1002/smll.201200575Search in Google Scholar PubMed · doi:10.1002/smll.201200575search
- [77] Gao L, Giglio KM, Nelson JL, Sondermann H, Travis AJ. Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination. Nanoscale 2014, 6, 2588–2593.10.1039/C3NR05422ESearch in Google Scholar PubMed PubMed Central · doi:10.1039/c3nr05422esearch
- [110] Dwidjosiswojo Z, Richard J, Moritz MM, Dopp E, Flemming HC, Wingender J. Influence of copper ions on the viability and cytotoxicity of Pseudomonas aeruginosa under conditions relevant to drinking water environments. Int. J. Hyg. Environ. Health 2011, 214, 485–492.10.1016/j.ijheh.2011.06.004Search in Google Scholar PubMed · doi:10.1016/j.ijheh.2011.06.004search
- [59] Walsh C, and Wright G. Introduction: antibiotic resistance. Chem. Rev. 2005, 105, 391–394.10.1021/cr030100ySearch in Google Scholar PubMed · doi:10.1021/cr030100ysearch
- [28] Chávez de Paz LE, Resin A, Howard KA, Sutherland DS, Wejse PL. Antimicrobial effect of chitosan nanoparticles on streptococcus mutans biofilms. Appl. Environ. Microbiol. 2011, 77, 3892–3895.10.1128/AEM.02941-10Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.02941-10search
- [53] Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiol. Read. Engl. 2009, 155(Pt 7), 2148–2156.10.1099/mic.0.028001-0Search in Google Scholar PubMed · doi:10.1099/mic.0.028001-0search
- 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
- [80] Jaiswal S, Bhattacharya K, McHale P, Duffy B. Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity. J. Mater. Sci. Mater. Med. 2015, 26, 1–10.10.1007/s10856-014-5367-1Search in Google Scholar PubMed · doi:10.1007/s10856-014-5367-1search
- [14] Kim MH, Yamayoshi I, Mathew S, Lin H, Nayfach J, Simon SI. Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection. Ann. Biomed. Eng. 2013, 41, 598–609.10.1007/s10439-012-0698-xSearch in Google Scholar PubMed · doi:10.1007/s10439-012-0698-xsearch
- [24] Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 2013, 65, 1803–1815.10.1016/j.addr.2013.07.011Search in Google Scholar PubMed · doi:10.1016/j.addr.2013.07.011search
- [39] Khan S, Alam F, Azam A, Khan AU. Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int. J. Nanomedicine 2012, 7, 3245–3257.10.2147/IJN.S31219Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s31219search
- [69] Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010, 35, 322–332.10.1016/j.ijantimicag.2009.12.011Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2009.12.011search
- 2013, Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms, Orthop. Rev., 5, 65
- [27] Chen CP, Chen CT, Tsai T. Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation. Photochem. Photobiol. 2012, 88, 570–576.10.1111/j.1751-1097.2012.01101.xSearch in Google Scholar PubMed · doi:10.1111/j.1751-1097.2012.01101.xsearch
- [49] Flemming HC, Wingender J. The biofilm matrix. Nat. Rev. Microbiol. 2010, 8, 623–633.10.1038/nrmicro2415Search in Google Scholar PubMed · doi:10.1038/nrmicro2415search
- [35] Baelo A, Levato R, Julián E, Crespo A, Astola J, Gavaldà J, Engel E, Mateos-Timoneda MA, Torrents E. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J. Controlled Release 2015, 209, 150–158.10.1016/j.jconrel.2015.04.028Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2015.04.028search
- 2015, Mucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patients, Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg., 272, 1079
- [66] Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 2003, 5, 1213–1219.10.1016/j.micinf.2003.08.009Search in Google Scholar PubMed · doi:10.1016/j.micinf.2003.08.009search
- [74] Maseda H, Sawada I, Saito K, Uchiyama H, Nakae T, Nomura N. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2004, 48, 1320–1328.10.1128/AAC.48.4.1320-1328.2004Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.48.4.1320-1328.2004search
- [60] Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 2002, 292, 107–113.10.1078/1438-4221-00196Search in Google Scholar PubMed · doi:10.1078/1438-4221-00196search
- [50] Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 2009, 5, 913–919.10.1038/nchembio.242Search in Google Scholar PubMed PubMed Central · doi:10.1038/nchembio.242search
- [61] Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 2000, 44, 1818–1824.10.1128/AAC.44.7.1818-1824.2000Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.44.7.1818-1824.2000search
- [8] Tollefson DF, Bandyk DF, Kaebnick HW, Seabrook GR, Towne JB. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch. Surg. Chic. Ill 1960. 1987, 122, 38–43.Search in Google Scholar
- [127] Song HY, Li Y. Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori? World J. Gastroenterol. 2013, 19, 6645–6650.10.3748/wjg.v19.i39.6645Search in Google Scholar PubMed · doi:10.3748/wjg.v19.i39.6645search
- [107] LewisOscar F, MubarakAli D, Nithya C, Priyanka R, Gopinath V, Alharbi NS, Thajuddin N. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling 2015, 31, 379–391.10.1080/08927014.2015.1048686Search in Google Scholar PubMed · doi:10.1080/08927014.2015.1048686search
- 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
- [83] Huang YC, Li RY, Chen JY, Chen JK. Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydr. Polym. 2016, 138, 114–122.10.1016/j.carbpol.2015.11.072Search in Google Scholar PubMed · doi:10.1016/j.carbpol.2015.11.072search
- [25] Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc. Jpn. Acad. Ser. B. 2012, 88, 53–71.10.2183/pjab.88.53Search in Google Scholar PubMed PubMed Central · doi:10.2183/pjab.88.53search
- [67] Lewis K. Persister cells and the riddle of biofilm survival. Biochem. Biochemistry (Moscow). 2005, 70, 267–274.10.1007/s10541-005-0111-6Search in Google Scholar PubMed · doi:10.1007/s10541-005-0111-6search
- [72] Rasamiravaka T, El Jaziri M. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr. Microbiol. 2016, 73, 747–753.10.1007/s00284-016-1101-1Search in Google Scholar PubMed · doi:10.1007/s00284-016-1101-1search
- 2012, Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, Int. J. Nanomedicine, 7, 4053
- [58] Brooks BD, Brooks AE. Therapeutic strategies to combat antibiotic resistance. Adv. Drug Deliv. Rev. 2014, 78, 14–27.10.1016/j.addr.2014.10.027Search in Google Scholar PubMed · doi:10.1016/j.addr.2014.10.027search
- [57] Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000, 406, 775–781.10.1038/35021219Search in Google Scholar PubMed · doi:10.1038/35021219search
- [12] Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez de Aberasturi D, de Larramendi IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30, 499–511.10.1016/j.tibtech.2012.06.004Search in Google Scholar PubMed · doi:10.1016/j.tibtech.2012.06.004search
- [34] Dong D, Thomas N, Thierry B, Vreugde S, Prestidge CA, Wormald PJ. Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm. PLoS One 2015, 10, e0131806.10.1371/journal.pone.0131806Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0131806search
- [86] Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 2008, 72, 157–165.10.1016/j.mimet.2007.11.010Search in Google Scholar PubMed · doi:10.1016/j.mimet.2007.11.010search
- [95] Wilson M, Dobson J, Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr. Microbiol. 1992, 25, 77–81.10.1007/BF01570963Search in Google Scholar PubMed · doi:10.1007/bf01570963search
- [79] Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 916–924.10.1016/j.nano.2011.11.007Search in Google Scholar PubMed · doi:10.1016/j.nano.2011.11.007search
- [46] Ramasamy M, Lee JH, Lee J. Potent antimicrobial and antibiofilm activities of bacteriogenically synthesized gold-silver nanoparticles against pathogenic bacteria and their physiochemical characterizations. J. Biomater. Appl. 2016, 31, 366–378.10.1177/0885328216646910Search in Google Scholar PubMed · doi:10.1177/0885328216646910search
- [64] Singh R, Paul D, Jain RK. Biofilms: implications in bioremediation. Trends Microbiol. 2006, 14, 389–397.10.1016/j.tim.2006.07.001Search in Google Scholar PubMed · doi:10.1016/j.tim.2006.07.001search
- [65] Umadevi S, Joseph NM, Kumari K, Easow JM, Kumar S, Stephen S, Srirangaraj S, Raj S. Detection of extended spectrum beta lactamases, ampc beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas Aeruginosa. Braz. J. Microbiol. 2011, 42, 1284–1288.10.1590/S1517-83822011000400006Search in Google Scholar PubMed PubMed Central · doi:10.1590/s1517-83822011000400006search
- [75] Rasamiravaka T, Jaziri ME. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr. Microbiol. 2016, 73, 747–753.10.1007/s00284-016-1101-1Search in Google Scholar · doi:10.1007/s00284-016-1101-1search
- [47] Cai J, Huang H, Song W, Hu H, Chen J, Zhang L, Li P, Wu R, Wu C. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. Int. J. Pharm. 2015, 495, 728–737.10.1016/j.ijpharm.2015.09.055Search in Google Scholar PubMed · doi:10.1016/j.ijpharm.2015.09.055search
- [87] Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA. Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surf. B Biointerfaces 2013, 102, 300–306.10.1016/j.colsurfb.2012.07.039Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2012.07.039search
- [96] Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995–4021.10.1016/j.biomaterials.2004.10.012Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2004.10.012search
- [109] Kruk T, Szczepanowicz K, Stefańska J, Socha RP, Warszyński P. Synthesis and antimicrobial activity of monodisperse copper nanoparticles. Colloids Surf. B Biointerfaces 2015, 128, 17–22.10.1016/j.colsurfb.2015.02.009Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2015.02.009search
- [33] Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009, 30, 2782–2789.10.1016/j.biomaterials.2009.01.052Search in Google Scholar PubMed PubMed Central · doi:10.1016/j.biomaterials.2009.01.052search
- [48] Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 2002, 56, 187–209.10.1146/annurev.micro.56.012302.160705Search in Google Scholar PubMed · doi:10.1146/annurev.micro.56.012302.160705search
- [92] Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, Huang FL, Dong RX, Lin JJ. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30, 5979–5987.10.1016/j.biomaterials.2009.07.030Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2009.07.030search
- [18] Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob. Agents Chemother. 2014, 58, 5818–5830.10.1128/AAC.03170-14Search in Google Scholar PubMed · doi:10.1128/aac.03170-14search
- [32] Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf. B Biointerfaces 2010, 79, 340–344.10.1016/j.colsurfb.2010.04.014Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2010.04.014search
- [123] Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J. Controlled Release 2008, 125, 193–209.10.1016/j.jconrel.2007.09.013Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2007.09.013search
- [89] Williams DF. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941–2953.10.1016/j.biomaterials.2008.04.023Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2008.04.023search
- [133] Zelver N, Hamilton M, Pitts B, Goeres D, Walker D, Sturman P, Heersink J. Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. Methods Enzymol. 1999, 310, 608–628.10.1016/S0076-6879(99)10047-8Search in Google Scholar PubMed · doi:10.1016/s0076-6879(99)10047-8search
- [52] Han Z, Pinkner JS, Ford B, Obermann R, Nolan W, Wildman SA, Hobbs D, Ellenberger T, Cusumano CK, Hultgren SJ, Janetka JW. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J. Med. Chem. 2010, 53, 4779–4792.10.1021/jm100438sSearch in Google Scholar PubMed PubMed Central · doi:10.1021/jm100438ssearch
- 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
- [90] Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 2014, 9, 373.10.1186/1556-276X-9-373Search in Google Scholar PubMed PubMed Central · doi:10.1186/1556-276x-9-373search
- [94] Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as amodel for Gram-negative bacteria. J. Colloid Interface Sci. 2004, 275, 177–182.10.1016/j.jcis.2004.02.012Search in Google Scholar PubMed · doi:10.1016/j.jcis.2004.02.012search
- [124] Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21, 2475–2490.10.1016/S0142-9612(00)00115-0Search in Google Scholar PubMed · doi:10.1016/s0142-9612(00)00115-0search
- [73] Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407, 762–764.10.1038/35037627Search in Google Scholar PubMed · doi:10.1038/35037627search
- [76] De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3, 133–149.10.2147/IJN.S596Search in Google Scholar · doi:10.2147/ijn.s596search
- [120] Del Carpio-Perochena A, Bramante CM, Duarte MAH, de Moura MR, Aouada FA, Kishen A. Chelating and antibacterial properties of chitosan nanoparticles on dentin. Restor. Dent. Endod. 2015, 40, 195–201.10.5395/rde.2015.40.3.195Search in Google Scholar PubMed PubMed Central · doi:10.5395/rde.2015.40.3.195search
- [54] Boyd A, Chakrabarty AM. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 1994, 60, 2355–2359.10.1128/aem.60.7.2355-2359.1994Search in Google Scholar PubMed PubMed Central · doi:10.1128/aem.60.7.2355-2359.1994search
- [20] Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 2002, 6, 319–327.10.1016/S1359-0286(02)00117-1Search in Google Scholar · doi:10.1016/s1359-0286(02)00117-1search
- [85] Welch K, Cai Y, Strømme M. A method for quantitative determination of biofilm viability. J. Funct. Biomater. 2012, 3, 418–431.10.3390/jfb3020418Search in Google Scholar PubMed PubMed Central · doi:10.3390/jfb3020418search
- [131] Herigstad B, Hamilton M, Heersink J. How to optimize the drop plate method for enumerating bacteria. J. Microbiol. Methods 2001, 44, 121–129.10.1016/S0167-7012(00)00241-4Search in Google Scholar PubMed · doi:10.1016/s0167-7012(00)00241-4search
- [129] Kho K, Cheow WS, Lie RH, Hadinoto K. Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy. Powder Technol. 2010, 203, 432–439.10.1016/j.powtec.2010.06.003Search in Google Scholar · doi:10.1016/j.powtec.2010.06.003search
- [141] Jones DS, Djokic J, Gorman SP. The resistance of polyvinylpyrrolidone-iodine-poly(-caprolactone) blends to adherence of Escherichia coli. Biomaterials 2005, 26, 2013–2020.10.1016/j.biomaterials.2004.06.001Search in Google Scholar PubMed · doi:10.1016/j.biomaterials.2004.06.001search
- [70] Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280, 295–298.10.1126/science.280.5361.295Search in Google Scholar PubMed · doi:10.1126/science.280.5361.295search
- [116] Messiaen AS, Forier K, Nelis H, Braeckmans K, Coenye T. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One 2013, 8, e79220.10.1371/journal.pone.0079220Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0079220search
- [111] Tabrez S, Khan, Ahamed M, Al-Khedhairy A, Musarrat J. Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation. Mater. Lett. 2013, 97, 67–70.10.1016/j.matlet.2013.01.085Search in Google Scholar · doi:10.1016/j.matlet.2013.01.085search
- [139] Forier K, Messiaen AS, Raemdonck K, Nelis H, De Smedt S, Demeester J, Coenye T, Braeckmans K. Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms. J. Controlled Release 2014, 195, 21–28.10.1016/j.jconrel.2014.07.061Search in Google Scholar PubMed · doi:10.1016/j.jconrel.2014.07.061search
- [68] Dawson CC, Intapa C, Jabra-Rizk MA. ‘Persisters’: survival at the cellular level. PLoS Pathog. 2011, 7, e1002121.10.1371/journal.ppat.1002121Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.ppat.1002121search
- [142] Yuan Y, Ai F, Zang X, Zhuang W, Shen J, Lin S. Polyurethane vascular catheter surface grafted with zwitterionic sulfobetaine monomer activated by ozone. Colloids Surf. B Biointerfaces 2004, 35, 1–5.10.1016/j.colsurfb.2004.01.005Search in Google Scholar PubMed · doi:10.1016/j.colsurfb.2004.01.005search
- [114] Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomedicine 2012, 7, 49–60.10.2147/IJN.S26766Search in Google Scholar PubMed PubMed Central · doi:10.2147/ijn.s26766search
- [99] Lu AH, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007, 46, 1222–1244.10.1002/anie.200602866Search in Google Scholar PubMed · doi:10.1002/anie.200602866search
- [29] Tan Y, Ma S, Liu C, Yu W, Han F. Enhancing the stability and antibiofilm activity of DspB by immobilization on carboxymethyl chitosan nanoparticles. Microbiol. Res. 2015, 178, 35–41.10.1016/j.micres.2015.06.001Search in Google Scholar PubMed · doi:10.1016/j.micres.2015.06.001search
- [137] Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl. Mater. Interfaces 2013, 5, 9322–9329.10.1021/am402618wSearch in Google Scholar PubMed · doi:10.1021/am402618wsearch
- [81] Cheow WS, Hadinoto K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology, 2012, 10, 327–333.10.1016/j.partic.2011.08.007Search in Google Scholar · doi:10.1016/j.partic.2011.08.007search
- [122] Hassani Najafabadi A, Abdouss M, Faghihi S. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen. Mater. Sci. Eng. C 2014, 41, 91–99.10.1016/j.msec.2014.04.035Search in Google Scholar PubMed · doi:10.1016/j.msec.2014.04.035search
- [11] Wu H, Moser C, Wang HZ, Høiby N, Song ZJ. Strategies for combating bacterial biofilm infections. Int. J. Oral Sci. 2015, 7, 1–7.10.1038/ijos.2014.65Search in Google Scholar PubMed PubMed Central · doi:10.1038/ijos.2014.65search
- [108] Ren G, Hu D, Cheng EWC, Vargas-Reus MA, Reip P, Allaker RP. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 2009, 33, 587–590.10.1016/j.ijantimicag.2008.12.004Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2008.12.004search
- [101] Kennedy J, Blair IS, McDowell DA, Bolton DJ. An investigation of the thermal inactivation of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled storage. J. Appl. Microbiol. 2005, 99, 1229–1235.10.1111/j.1365-2672.2005.02697.xSearch in Google Scholar PubMed · doi:10.1111/j.1365-2672.2005.02697.xsearch
- [145] Curtis LT. Prevention of hospital-acquired infections: review of non-pharmacological interventions. J. Hosp. Infect. 2008, 69, 204–219.10.1016/j.jhin.2008.03.018Search in Google Scholar PubMed PubMed Central Received: 2016-7-1 Accepted: 2016-10-18 Published Online: 2017-1-13 Published in Print: 2017-10-26 ©2017 Walter de Gruyter GmbH, Berlin/Boston This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Skip Articles in the same Issue Articles in the same Issue Frontmatter In this issue Reviews Recent developments in the use of nanoparticles for treatment of biofilms Biomaterial-based nanoreactors, an alternative for enzyme delivery The role of defects and dimensionality in influencing the charge, capacitance, and energy storage of graphene and 2D materials Hydrogel based 3D carriers in the application of stem cell therapy by direct injection Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma Nanomaterials for cancer therapies Readers are also interested in: article: Mechanical and thermal characterization of Kevlar–Basalt hybrid composites reinforced with Al2O3 nanoparticles Mechanical and thermal characterization of Kevlar–Basalt hybrid composites reinforced with Al2O3 nanoparticles article: A bibliometric and visual analysis of the current status and future prospects of nanotechnology in fracture healing research(1995–2025) A bibliometric and visual analysis of the current status and future prospects of nanotechnology in fracture healing research(1995–2025) article: Improving bending fatigue lifetime and interfacial adhesion of Cu–Mn flexible interconnects using self-forming nanolayer Improving bending fatigue lifetime and interfacial adhesion of Cu–Mn flexible interconnects using self-forming nanolayer https://doi.org/10.1515/ntrev-2016-0054 Keywords for this article antibiotic resistance; bacterial infection; biofilm; drug delivery; nanoparticles Creative Commons BY-NC-ND 3.0 Skip Articles in the same Issue Articles in the same Issue Frontmatter In this issue Reviews Recent developments in the use of nanoparticles for treatment of biofilms Biomaterial-based nanoreactors, an alternative for enzyme delivery The role of defects and dimensionality in influencing the charge, capacitance, and energy storage of graphene and 2D materials Hydrogel based 3D carriers in the application of stem cell therapy by direct injection Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma Nanomaterials for cancer therapies · doi:10.1016/j.jhin.2008.03.018search
- [13] Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 2001, 183, 6746–6751.10.1128/JB.183.23.6746-6751.2001Search in Google Scholar PubMed · doi:10.1128/jb.183.23.6746-6751.2001search
- [126] Iannitelli A, Grande R, Di Stefano A, Di Giulio M, Sozio P, Bessa LJ, Laserra S, Paolini C, Protasi F, Cellini L. Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int. J. Mol. Sci. 2011, 12, 5039–5051.10.3390/ijms12085039Search in Google Scholar PubMed · doi:10.3390/ijms12085039search
- [105] Ramyadevi J, Jeyasubramanian K, Marikani A, Rajakumar G, Rahuman AA. Synthesis and antimicrobial activity of copper nanoparticles. Mater. Lett. 2012, 71, 114–116.10.1016/j.matlet.2011.12.055Search in Google Scholar · doi:10.1016/j.matlet.2011.12.055search
- [138] Seneviratne CJ, Leung KC, Wong CH, Lee SF, Li X, Leung PC, Lau CB, Wat E, Jin L. Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms. PLoS One 2014, 9, e103234.10.1371/journal.pone.0103234Search in Google Scholar PubMed PubMed Central · doi:10.1371/journal.pone.0103234search
- [121] de Salamanca AE, Diebold Y, Calonge M, García-Vazquez C, Callejo S, Vila A, Alonso MJ. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Investig. Opthalmology Vis. Sci. 2006, 47, 1416.10.1167/iovs.05-0495Search in Google Scholar PubMed · doi:10.1167/iovs.05-0495search
- [100] Yantasee W, Warner CL, Sangvanich T, Addleman RS, Carter TG, Wiacek RJ, Fryxell GE, Timchalk C, Warner MG. Removal of heavy metals from aqueous systems with thiol functionalized superparamagnetic nanoparticles. Environ. Sci. Technol. 2007, 41, 5114–5119.10.1021/es0705238Search in Google Scholar PubMed · doi:10.1021/es0705238search
- [98] Salunkhe AB, Khot VM, Pawar SH. Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr. Top. Med. Chem. 2014, 14, 572–594.10.2174/1568026614666140118203550Search in Google Scholar PubMed · doi:10.2174/1568026614666140118203550search
- [135] Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles. ACS Nano 2011, 5, 7235–7244.10.1021/nn202054fSearch in Google Scholar PubMed PubMed Central · doi:10.1021/nn202054fsearch
- [112] Shankar S, Rhim JW. Effect of copper salts and reducing agents on characteristics and antimicrobial activity of copper nanoparticles. Mater. Lett. 2014, 132, 307–311.10.1016/j.matlet.2014.06.014Search in Google Scholar · doi:10.1016/j.matlet.2014.06.014search
- [132] Naghili H, Tajik H, Mardani K, Razavi Rouhani SM, Ehsani A, Zare P. Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests. Vet. Res. Forum 2013, 4, 179–183.Search in Google Scholar PubMed
- [140] Paladini F, Pollini M, Sannino A, Ambrosio L. Metal-based antibacterial substrates for biomedical applications. Biomacromolecules 2015, 16, 1873–1885.10.1021/acs.biomac.5b00773Search in Google Scholar PubMed · doi:10.1021/acs.biomac.5b00773search
- 2013, Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era, Cold Spring Harb. Perspect. Med., 3, a010306
- [97] Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 1981, 17, 1247–1248.10.1109/TMAG.1981.1061188Search in Google Scholar · doi:10.1109/tmag.1981.1061188search
- [118] Machul A, Mikołajczyk D, Regiel-Futyra A, Heczko PB, Strus M, Arruebo M, Stochel G, Kyzioł A. Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains. J. Biomater. Appl. 2015, 30, 269–278.10.1177/0885328215578781Search in Google Scholar PubMed · doi:10.1177/0885328215578781search
- [130] Chen CY, Nace GW, Irwin PL. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J. Microbiol. Methods 2003, 55, 475–479.10.1016/S0167-7012(03)00194-5Search in Google Scholar PubMed · doi:10.1016/s0167-7012(03)00194-5search
- 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
- 2015, Current development of silver nanoparticle preparation, investigation, and application in the field of medicine, current development of silver nanoparticle preparation, investigation, and application in the field of medicine, J. Nanomater. J. Nanomater., 2015, e696918, 10.1155/2015/696918 · DOI · Paper page
- [115] Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R, Mackinson C, James G, Fisher S, Perkins WR. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 2008, 61, 859–868.10.1093/jac/dkn059Search in Google Scholar PubMed · doi:10.1093/jac/dkn059search
- [103] Borcherding J, Baltrusaitis J, Chen H, Stebounova L, Wu CM, Rubasinghege G, Mudunkotuwa IA, Caraballo JC, Zabner J, Grassian VH, Comellas AP. Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function. Environ. Sci. Nano 2014, 1, 123–132.10.1039/c3en00029jSearch in Google Scholar PubMed PubMed Central · doi:10.1039/c3en00029jsearch
- [128] Beyth N, Yudovin-Farber I, Perez-Davidi M, Domb AJ, Weiss EI. Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo. Proc. Natl. Acad. Sci. USA. 2010, 107, 22038–22043.10.1073/pnas.1010341107Search in Google Scholar · doi:10.1073/pnas.1010341107search
- [102] Nguyen TK, Duong HTT, Selvanayagam R, Boyer C, Barraud N. Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy. Sci. Rep. 2015, 5, 18385.10.1038/srep18385Search in Google Scholar PubMed PubMed Central · doi:10.1038/srep18385search
- 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
- [2] Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 2001, 45, 999–1007.10.1128/AAC.45.4.999-1007.2001Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.45.4.999-1007.2001search
- [62] Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 2003, 47, 317–323.10.1128/AAC.47.1.317-323.2003Search in Google Scholar PubMed PubMed Central · doi:10.1128/aac.47.1.317-323.2003search
- [117] Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003, 4, 1457–1465.10.1021/bm034130mSearch in Google Scholar PubMed · doi:10.1021/bm034130msearch
- [136] Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J. Am. Chem. Soc. 2007, 129, 4612–4619.10.1021/ja0674338Search in Google Scholar PubMed · doi:10.1021/ja0674338search
- [119] Ali SW, Rajendran S, Joshi M. Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester. Carbohydr. Polym. 2011, 83, 438–446.10.1016/j.carbpol.2010.08.004Search in Google Scholar · doi:10.1016/j.carbpol.2010.08.004search
- [113] Shek PN, Yung BY, Stanacev NZ. Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation. Immunology 1983, 49, 37–44.Search in Google Scholar PubMed
- [125] Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomedicine 2011, 6, 877–895.10.2147/IJN.S18905Search in Google Scholar PubMed · doi:10.2147/ijn.s18905search
- [91] Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3, 95–101.10.1016/j.nano.2006.12.001Search in Google Scholar PubMed · doi:10.1016/j.nano.2006.12.001search
- [144] Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int. J. Antimicrob. Agents 2009, 34, 103–110.10.1016/j.ijantimicag.2009.01.017Search in Google Scholar PubMed · doi:10.1016/j.ijantimicag.2009.01.017search
Cited by
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520
Metal Oxide Nanoparticles Against Bacterial Biofilms: Perspectives and Limitations
Shkodenko, L., Kassirov, I., & Koshel, E. (2020) · Microorganisms · doi:10.3390/microorganisms8101545 · Cited by 296
“They can cause many problems in various areas: water treatment (biofilm can disrupt the microbial community of active silt) [7]; food production (biofilm formation by pathogenic microorganisms and spoilage microorganisms) [8]; implantology (biofilms are capable of infecting medical devices: intravenous catheters, vasc…”
BackgroundThe effect of nano-SiO2 on concrete properties: a review
Zhuang, C., & Chen, Y. (2019) · Nanotechnology Reviews · doi:10.1515/ntrev-2019-0050 · Cited by 193
Antibacterial Activity of TiO2 Nanoparticles Prepared by One-Step Laser Ablation in Liquid
Khashan, K. S., Sulaiman, G. M., Abdulameer, F. A., Albukhaty, S., Ibrahem, M. A., Al-Muhimeed, T., & AlObaid, A. A. (2021) · Applied Sciences · doi:10.3390/app11104623 · Cited by 182
“The bactericidal property of TiO2 NPs depends on their size, stability, and concentration added to the growth medium, which provides greater retention time for bacterium NP interaction, allowing them to interact closely with microbial membranes [23,24].”
BackgroundPolymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies
Anju, V. T., Busi, S., Imchen, M., Kumavath, R., Mohan, M. S., Salim, S. A., Subhaswaraj, P., & Dyavaiah, M. (2022) · Antibiotics · doi:10.3390/antibiotics11121731 · Cited by 177
Silver and Gold Nanoparticles for Antimicrobial Purposes against Multi-Drug Resistance Bacteria
Rabiee, N., Ahmadi, S., Akhavan, O., & Luque, R. (2022) · Materials · doi:10.3390/ma15051799 · Cited by 169
“Au NPs can be synthesized by reducing gold salts through several completely fixed methods [128,129].”
BackgroundMethodPotential applications of engineered nanoparticles in medicine and biology: an update
Rudramurthy, G. R., & Swamy, M. K. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1600-6 · Cited by 171
Permana, A. D., Mir, M., Utomo, E., & Donnelly, R. F. (2020) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2020.100047 · Cited by 148
Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases
Rodrigues, G. R., López‐Abarrategui, C., Gómez, I. D. L. S., Dias, S. C., Otero‐González, A. J., & Franco, O. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.043 · Cited by 132
The role of nanotechnology in combating biofilm-based antibiotic resistance
Malaekeh‐Nikouei, B., Bazzaz, B. S. F., Mirhadi, E., Tajani, A. S., & Khameneh, B. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101880 · Cited by 129
Permana, A. D., Anjani, Q. K., Sartini, S., Utomo, E., Volpe‐Zanutto, F., Paredes, A. J., Evary, Y. M., Mardikasari, S. A., Pratama, M. R., Tuany, I. N., et al. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111786 · Cited by 115
Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
Yang, G., Chen, S., & Zhang, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00751 · Cited by 114
“Unfortunately, vaccines remain unavailable for many infectious diseases (Haque et al., 2018), such as Chlamydia and M. tuberculosis infections.”
BackgroundNanoparticles approach to eradicate bacterial biofilm-related infections: A critical review
Al-Wrafy, F. A., Al-Gheethi, A. A. S., Ponnusamy, S. K., Noman, E. A., & Fattah, S. A. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.132603 · Cited by 112
A Machine Learning Tool to Predict the Antibacterial Capacity of Nanoparticles
Mirzaei, M., Furxhi, I., Murphy, F., & Mullins, M. (2021) · Nanomaterials · doi:10.3390/nano11071774 · Cited by 114
“NPs have been studied for their capacity to inhibit microbial infections [18] and prevent bacterial colonization on various surface devices such as catheters [19] and prostheses [20] by eradicating biofilms [21,22].”
BackgroundSchneider‐Futschik, E. K., & Reyes‐Ortega, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081157 · Cited by 100
“Magnetic hyperthermia can be effectively used to decrease biofilm and mucus viscosity, while enhancing drug and immune cell penetration into the target areas [100].”
BackgroundCurrent developments in biofilm treatments: Wound and implant infections
Dhar, Y., & Han, Y. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.07.003 · Cited by 114
Advanced drug delivery and therapeutic strategies for tuberculosis treatment
Nair, A., Greeny, A., Nandan, A., Sah, R. K., Jose, A., Dyawanapelly, S., Junnuthula, V., Athira, K. V., & Sadanandan, P. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02156-y · Cited by 121
“The formulations need to be optimized to penetrate mucous layers and biofilms and overcome sequestration, rapid deactivation by enzymes, and elimination by coughing [265, 266].”
BackgroundAntibacterial nanomaterials: Upcoming hope to overcome antibiotic resistance crisis
Hochvaldová, L., Večeřová, R., Kolář, M., Prucek, R., Kvítek, L., Lapčík, L., & Panáček, A. (2022) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0059 · Cited by 96
PLGA-Based Nanoplatforms in Drug Delivery for Inhibition and Destruction of Microbial Biofilm
Shariati, A., Chegini, Z., Ghaznavi‐Rad, E., Zare, E. N., & Hosseini, S. M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926363 · Cited by 91
Nanomaterials: The New Antimicrobial Magic Bullet
Ndayishimiye, J., Kumeria, T., Popat, A., Falconer, J. R., & Blaskovich, M. A. T. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00660 · Cited by 81
Nanomaterials enabling clinical translation of antimicrobial photodynamic therapy
Awad, M., Thomas, N., Barnes, T. J., & Prestidge, C. A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.035 · Cited by 74
Nanomaterials for Treating Bacterial Biofilms on Implantable Medical Devices
Tran, H. M., Tran, H. A., Booth, M. A., Fox, K. E., Nguyen, H. T., Tran, N. L., & Tran, P. A. (2020) · Nanomaterials · doi:10.3390/nano10112253 · Cited by 72
Mulat, M., Banicod, R. J. S., Tabassum, N., Javaid, A., Karthikeyan, A., Jeong, G., Kim, Y., Jung, W., & Khan, F. (2025) · Antibiotics · doi:10.3390/antibiotics14060555 · Cited by 81
Permana, A. D., Mir, M., Utomo, E., & Donnelly, R. F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119220 · Cited by 57
“Accordingly, chitosan is anticipated to exhibit a high attraction to infected areas (Han et al., 2017).”
BackgroundRetractedGut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance
Kelly, S. A., Rodgers, A. M., O’Brien, S., Donnelly, R. F., & Gilmore, B. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.10.008 · Cited by 62
Targeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis?
Chew, S.-S., Tan, L. T., Law, J. W., Pusparajah, P., Goh, B. H., Mutalib, N. A., & Lee, L. (2020) · Cancers · doi:10.3390/cancers12082272 · Cited by 64
“The use of nanoparticles with inherently antimicrobial activity, such as silver nanoparticles, to treat biofilms has been extensively explored [161,162], while the study of nanoparticles to deliver small molecules or quorum sensing inhibitors to biofilms is relatively limited.”
BackgroundSelected strategies to fight pathogenic bacteria
Plotniece, A., Sobolev, A., Supuran, C. T., Carta, F., Björkling, F., Franzyk, H., Yli‐Kauhaluoma, J. T., Augustyns, K., Cos, P., Vooght, L. D., et al. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2155816 · Cited by 64
Purbayanto, M. A. K., Jakubczak, M., Bury, D., Nair, V. G., Birowska, M., Moszczyńska, D., & Jastrzębska, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c00365 · Cited by 55
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles
Khorsandi, K., Keyvani‐Ghamsari, S., Shahidi, F. K., Hosseinzadeh, R., & Kanwal, S. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1895818 · Cited by 61
“The nanoscale materials have a higher surface-to-volume ratio compared to larger particles of the same chemical composition, which makes them biologically more active [129].”
BackgroundFulaz, S. F., Devlin, H., Vitale, S., Quinn, L., O’Gara, J. P., & Casey, E. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s256227 · Cited by 55
Al-Momani, H., Almasri, M., Balawi, D. A., Hamed, S., Albiss, B. A., Aldabaibeh, N., Ibrahim, L., Albalawi, H., Mahmoud, S. A. H., Khasawneh, A. I., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35919-6 · Cited by 62
Effects of Metal and Metal Oxide Nanoparticles against Biofilm-Forming Bacteria: A Systematic Review
Algadi, H., Alhoot, M. A., Al‐Maleki, A. R., & Purwitasari, N. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2403.03029 · Cited by 50
“However, the effectiveness of these nanoparticles may vary depending on factors such as biofilm maturity, surface composition, nanoparticle size, surface charge, and nanoparticles concentration [15, 17, 34].”
BackgroundChlumsky, O., Purkrtová, S., Míchová, H., Sýkorová, H., Slepička, P., Fajstavr, D., Ulbrich, P., Viktorová, J., & Demnerová, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157892 · Cited by 52
Kapustová, M., Puškárová, A., Bučková, M., Granata, G., Napoli, E., Annušová, A., Mesárošová, M., Kozics, K., Pangallo, D., & Geraci, C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120846 · Cited by 42
Rashki, S., Dawi, E. A., Zilaei, M. R., Safardoust-Hojaghan, H., Ghanbari, M., Ryadh, A., Lafta, H. A., Khaledi, A., & Salavati‐Niasari, M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127583 · Cited by 41
Liu, Y., Yoo, E., Han, C., Mahler, G. J., & Doiron, A. L. (2018) · NanoImpact · doi:10.1016/j.impact.2018.02.007 · Cited by 37
“Titanium dioxide (TiO2), silicon dioxide (SiO2), and polystyrene (PS) NPs are widely used in the food and food packaging industries, cosmetic products, and biomedical applications, which makes them the most commonly used in human contact situations [16]–[20].”
BackgroundSelf-citationGopalakrishnan, V., Esakkirajan, M., Ramkumar, V. S., Baskaraligam, V., & Selvaraj, G. (2020) · Journal of Basic Microbiology · doi:10.1002/jobm.201900537 · Cited by 33
“Protein encapsulation affords nanoscale compartments on the surface of the nanoparticles for the transport of drugs [26,27], also acting as an efficient carrier for cancer treatment [28].”
BackgroundVillegas-Fuentes, A., la Torre, A. R.-D., Vilchis-Nestor, A. R., & Luque, P. A. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.139577 · Cited by 32
Zang, Y., Zhang, W., Wang, W., Zhao, X., & Wang, X. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100217 · Cited by 41
Zhou, J., Zhang, Y., Ding, J., Fang, J., Yang, J., Xie, Y., & Xu, X. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c16135 · Cited by 33
Al-Momani, H., Aolymat, I., Ibrahim, L., Albalawi, H., Al Balawi, D., Albiss, B. A., Almasri, M., & Alghweiri, S. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03441-y · Cited by 33
“…exposure to the ZnO NP. Similar to the results of the turbidity method, the results of the bacterial colony counting demonstrated a significant (F [10, 11] = 10.42, p 0:05) dose-dependent reduction in the number of bacterial colonies for all the tested strains apart o f PA5 and PA6 at…”
BackgroundResultInfluentialApplication of cationic polymer micelles for the dispersal of bacterial biofilms
Borisova, D., Haladjova, E., Kyulavska, M., Petrov, P. D., Pispas, S., Stoitsova, S. R., & Paunova-Krasteva, T. S. (2018) · Engineering in Life Sciences · doi:10.1002/elsc.201800040 · Cited by 33
Pulmonary biofilm-based chronic infections and inhaled treatment strategies
Ding, L., Wang, J., Cai, S., Smyth, H. D. C., & Cui, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120768 · Cited by 38
Khan, F., Park, S., Bamunuarachchi, N. I., Oh, D. K., & Kim, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11300-3 · Cited by 31
“Although the mechanism of biofilm inhibition by various types of nanoparticles has not been reported (Banerjee et al. 2020; Han et al. 2017), a few reports have suggested that nanoparticles inhibit gene expression changes associated with the motility and biofilm formation by bacterial cells (de la…”
BackgroundHan, C., Goodwine, J. S., Romero, N., Kyle, S. S., Sauer, K., & Doiron, A. L. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110512 · Cited by 33
“Antibiotics are a primary therapy option for biofilm infections, yet high doses are required, which can be problematic due to concerns over toxicity and the selection of antibiotic-resistant bacteria [5].”
BackgroundSelf-citationRahman, S., Sadaf, S., Hoque, M. E., Mishra, A., Mubarak, N. M., Malafaia, G., & Singh, J. (2024) · RSC Advances · doi:10.1039/d3ra05816f · Cited by 35
Nanoparticles targeting biofilms: A new era in combating antimicrobial resistance
Joshi, A., & Patil, R. H. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100156 · Cited by 38
An efficient treatment of biofilm-induced periodontitis using Pt nanocluster catalysis
Wu, T., Sun, J., Lei, J., Fan, Q., Tang, X., Zhu, G., Yan, Q., Feng, X., & Shi, B. (2021) · Nanoscale · doi:10.1039/d1nr05198a · Cited by 26
Enhanced Bactericidal Effects and Drug Delivery with Gentamicin-Conjugated Nanoparticles
Athauda, I. D., Shetty, M., Pai, P. G., Hegde, M., Gurumurthy, S. C., & Babitha, K. S. (2023) · Journal of Cluster Science · doi:10.1007/s10876-023-02501-z · Cited by 31
“…could enhance the bactericidal activity, such as their potential to attach to or penetrate the cell wall, resulting in the delivery of a greater number of gentamicin molecules into a highly localized volume as each nanoparticle is surrounded by several drug moieties acting as a sole group [112 ].”
Ivanova, A., Ivanova, K., & Tzanov, T. (2021) · Nanomaterials · doi:10.3390/nano11113143 · Cited by 24
Singh, A. K., Verma, A., Singh, R., Sahoo, A. K., & Samanta, S. K. (2020) · Nanotechnology · doi:10.1088/1361-6528/abc2ed · Cited by 25
“Besides, it was found that the leaf extract of papaya can demonstrate antimicrobial and antibiofilm properties [34].”
BackgroundTan, M., Reyes‐Ortega, F., & Schneider‐Futschik, E. K. (2020) · Magnetochemistry · doi:10.3390/magnetochemistry6040072 · Cited by 18
“, magnetic hyperthermia combining pharmaceutical agents and drug delivery as carriers themselves [2].”
BackgroundInfluentialAntibiotic Resistant Biofilms and the Quest for Novel Therapeutic Strategies
Surekha, S., Lamiyan, A. K., & Gupta, V. (2023) · Indian Journal of Microbiology · doi:10.1007/s12088-023-01138-w · Cited by 20
“High permeability, inhibition of antibiotic-EPS binding, inhibiting enzymatic inactivation, and transporting medications to the infection site in an optimum dose are all benefits of nanoparticles for pharmaceutical administration [102, 103].”
Cationized silica ceria nanocomposites to target biofilms in chronic wounds
Rasool, N., Srivastava, R., & Singh, Y. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212939 · Cited by 15
Effect of ultrasound amplitude and frequency on nanoparticle diffusion in an agarose hydrogel
Karki, A., Marshall, J. S., & Wu, J. (2022) · The Journal of the Acoustical Society of America · doi:10.1121/10.0012972 · Cited by 15
Asif, N., Fatima, S., Siddiqui, T., & Fatma, T. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127069 · Cited by 16
Green Synthesis of Manganese Dioxide Nanoparticles and its Biological
Shanshool, S. K., & Shanan, Z. J. (2023) · Baghdad Science Journal · doi:10.21123/bsj.2023.8385 · Cited by 14
Abdelkarim, E. A., Elsamahy, T., Bayomi, R. M. E., Hussein, M. A., Darwısh, I. A., El-tahlawy, A. S., Alahmad, W., Darling, R. J., Hafez, A.-E. E., Sobhi, M., et al. (2025) · Aquaculture International · doi:10.1007/s10499-025-01952-7 · Cited by 20
“However, several other considerations must be considered, including NP type, the bacterial strain, the quantity of NPs, the quantification techniques, and the biofilm-growing environment (Han et al. 2017).”
Caf, M., Esmaeilnejad-Ahranjani, P., Kolosnjaj‐Tabi, J., Sabotič, J., Berlec, A., Zaveršek, N., Pajk, S., Zahirović, A., Golzio, M., Milošević, I., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c14390 · Cited by 19
Antimicrobial Antioxidant Polymer Films with Green Silver Nanoparticles from Symphyti radix
Balčiūnaitienė, A., Januskevice, V., Saunoriūtė, S., Raubyte, U., Viškelis, J., Memvanga, P. B., & Viškelis, P. (2024) · Polymers · doi:10.3390/polym16030317 · Cited by 14
“These materials show strong antimicrobial activity against resistant bacteria due to their high surface area-to-volume ratios, resulting in higher ratios between atoms on the surface and atoms on the inside of materials in comparison with corresponding bulk materials [14,15].”
BackgroundMagnetic nanoparticle interaction with a hydrogel in an oscillating magnetic field
Ahmadinejad, M., & Marshall, J. S. (2024) · Physics of Fluids · doi:10.1063/5.0177375 · Cited by 11
Pore-scale modelling of particle transport in a porous bed
Storm, R., & Marshall, J. S. (2024) · Journal of Fluid Mechanics · doi:10.1017/jfm.2023.1058 · Cited by 13
Development of “Intelligent particles” for the treatment of dental caries
He, Y., Bright, R., Vasilev, K. A., & Zilm, P. S. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114374 · Cited by 12
Francis, D., Hari, G. V., Subash, A. K., Bhairaddy, A., & Joy, A. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.08.002 · Cited by 14
Nickel Oxide Nanoparticles: Synthesis and Evaluation for Antimicrobial Efficacy
Shanan, Z. J., & Shanshool, S. K. (2022) · International Journal of Nanoscience · doi:10.1142/s0219581x23500084 · Cited by 10
Simsekli, O., Bilinmis, I., Celik, S., Arik, G., Baba, A. Y., & Karaküçük, A. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2270619 · Cited by 11
“As a result of their tiny stature, they may easily go beneath into the biofilm layer, causing irreparable damage to the cell membrane and internal contents [36,38,39].”
BackgroundXie, Y., Wei, W., Meng, F., Qu, X., Li, J., Wang, L., & Zhou, Z. (2019) · Nanotechnology Reviews · doi:10.1515/ntrev-2019-0030 · Cited by 10
Jiang, N., Zhao, S., Wang, S., & Lu, Z. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s333432 · Cited by 10
Ma, X., Yang, N., Mao, R., Hao, Y., Teng, D., Huang, Y., & Wang, J. (2024) · Antibiotics · doi:10.3390/antibiotics13030228 · Cited by 11
“…greatly exacerbated the development of bacterial resistance, and the formation of bacterial biofilms, which allow bacteria to evade the effects of antibiotics on the bacteria within the biofilm, has further exacerbated the resistance situation, posing a major threat to public health safety [1–3].”
BackgroundKumar, M., Gupta, G., Varghese, T., Shankregowda, A. M., Srivastava, P. P., Bhushan, S., Shukla, S. P., Krishna, G., & Gupta, S. (2021) · Current Nanoscience · doi:10.2174/1573413717666210531153107 · Cited by 9
Saleh, N. M., Elshaer, S. L., & Girgis, G. N. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210708105142 · Cited by 12
Marzaman, A. N. F., Mahfufah, U., Fauziah, N., Rahman, F. U. A., Hidayati, N., Hasyim, R., Setiawati, D., Choiri, S., Nuzulia, N. A., Madani, A. F., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c08967 · Cited by 9
Restoring Ocular Microbiota Balance: A New Bioprinted Approach to Treating Anterior Segment Diseases
Rusciano, D. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl28268 · Cited by 7
Lange, A., Sawosz, E., Daniluk, K., Wierzbicki, M., Małolepszy, A., Gołębiewski, M., & Jaworski, S. (2022) · Nanomaterials · doi:10.3390/nano12173058 · Cited by 8
“Even though most bacteria species are able to live in a biofilm structure, which is more complicated and different from that of planktonic cells [17], biofilm formation, nonetheless, starts with the adherence of free-floating planktonic bacteria cells to the surfaces [18].”
BackgroundKadhim, R. J., Jabir, M. S., Sulaiman, G. M., Nayef, U. M., Mohammed, H. A., & Abomughaid, M. M. (2025) · Plasmonics · doi:10.1007/s11468-025-03134-w · Cited by 7
“Despite the fact that metal-based nanoparticles have non-specific bacterial toxicity mechanisms, bacteria can still develop resistance through a variety of mechanisms, including biofilm formation and efflux pump [134, 135].”
Park, C., Kim, T., Seol, J., Joshi, B. N., Aldalbahi, A. K., Hong, J.-H., An, S., & Yoon, S. S. (2023) · Applied Surface Science · doi:10.1016/j.apsusc.2023.158376 · Cited by 8
Magnetic hybrid nanoparticles for drug delivery
Singh, S., Chawla, H., Chandra, A., & Garg, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823688-8.00034-x · Cited by 8
Bello, G. L., Dellacasa, E., Damonte, G., Caviglia, D., Schito, A. M., Raiteri, R., Monticelli, O., Sartini, M., Cristina, M. L., & Pastorino, L. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42934 · Cited by 5
“With regard to the development of innovative approaches in this field, the use of nanomaterials to combat bacterial biofilm associated infections has been widely studied [18,19].”
Le, P. H., Huynh, T. P., Chu, T.-P., Nguy, L. T., Uyen, N. N., & Vinh, T. C. M. (2025) · Nanoscale Advances · doi:10.1039/d4na00997e · Cited by 7
Magnetomechanical Detachment of Bacterial Biofilms Using Anisotropic Magnetic Iron Oxide Nanochains
Šavli, M., Černila, M., Caf, M., Zahirović, A., Zaveršek, N., Nemec, S., Stojanov, S., Klančnik, A., Sabotič, J., Kralj, S., et al. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01029 · Cited by 9
Chitosan/Arabic gum /ZnO bionanocomposite as a novel antibacterial agent
Safaei, M., Mobarakeh, M. S., Azizi, B., Shoohanizad, E., Wong, L. S., & Nikkerdar, N. (2024) · Polimery · doi:10.14314/polimery.2024.6.4 · Cited by 5
Reddy, T. S., Hadi, M. A., Navanita, S. K., Karri, V. N. R., Pagar, K. P., & Shanker, K. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s06.264 · Cited by 4
Platelet membrane-camouflaged PLGA loaded natamycin improve the prognosis of fungal keratitis
Zhang, Y., Liu, X., Hou, Y., Cui, L., Wang, Q., Peng, X., Jiang, N., Zhao, G., & Lin, J. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214239 · Cited by 3
Mohanty, S., & Paul, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822956-9.00005-2 · Cited by 4
Mentha longifolia assisted nanostructures: An approach to obliterate microbial biofilms
Kazmi, M. B., Almutairi, H. H., Andleeb, A., Jabeen, R., Mustafa, G., Habiba, U.-E., Kazmi, S. A., Naz, F., & Qammar, N. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303521 · Cited by 3
Ma, X., Dong, Z., Mao, R., Tian, X., Yang, N., Ren, W., Hao, Y., Shen, W., Teng, D., Li, X., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111350 · Cited by 3
Yamamoto, N., Tagami, T., Ogawa, K., & Ozeki, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00592 · Cited by 3
Biotechnological Approaches in Infectious Diseases
Banerjee, S., Bose, S., Shukla, A. C., & Baig, M. R. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-1148-2_15 · Cited by 3
Nanodrug Therapy for Salmonella Biofilm Disruption
Rangra, S., Prajapati, A., Rana, D., Desai, N., Upadhyay, A., Palanimuthu, V. R., Benival, D. M., & Vora, L. K. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677047-00203 · Cited by 3
Nanotechnology Enabled Solutions to Combat Covid-19: Prevention, Treatment, and Diagnosis
Musyuni, P., Nagpal, M., Singh, M., Goyal, R. K., & Aggarwal, G. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210122124311 · Cited by 3
Melnikova, N. B., Malygina, D., Vorobyova, O., Solovyeva, A. G., Belyaeva, К. L., Orekhov, D. V., & Knyazev, A. V. (2021) · Russian Chemical Bulletin · doi:10.1007/s11172-021-3084-8 · Cited by 3
Rani, D., Pai, M. O., Gupta, P., Verma, S., Banerjee, U. C., & Kalita, D. (2023) · Research Square · doi:10.21203/rs.3.rs-2904921/v1 · Cited by 3
Nanoparticle-based treatment of bacterial biofilms
Tata, P., Bhavya, K. S., Ganesan, R., & Dutta, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00029-1 · Cited by 2
Carbon Nanomaterials for Wastewater Treatment
Kumari, S., Kaur, M., & Dhania, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-31111-6_11 · Cited by 2
Mohanty, S., & Paul, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822503-5.00015-1 · Cited by 5
Mukherjee, D., Sil, M., Bhattacharya, D., Lahiri, D., Goswami, A., & Nag, M. (2024) · BioNanoScience · doi:10.1007/s12668-024-01689-2 · Cited by 1
Chandramoorthy, H. C. K. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128394608251005230040 · Cited by 1
Behroozi, A. H., Amini, G., Shirazi, R. J., & Koupaie, E. H. (2025) · Carbon Resources Conversion · doi:10.1016/j.crcon.2025.100403 · Cited by 1
Chaudhary, G., Verma, A., Maurya, S., Singh, R., Tyagi, S., Manna, B., Katara, P., Prabhakar, A., Verma, D., & Yadav, A. B. (2025) · ACS Omega · doi:10.1021/acsomega.5c05577 · Cited by 1
Pu, Y., Chen, S., & Zeng, H. (2026) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2026.103956 · Cited by 1
Metadata
- Authors
- Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L.
- Affiliations
- Binghamton University (US)
- Corresponding author
- Doiron, Amber L.
- ORCID
- Doiron, Amber L.
- Venue
- Nanotechnology Reviews
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-10-26
- Volume
- 6
- Issue
- 5
- Pages
- 383-404
- ISSN
- 2191-9089 (ISSN-L)
- 2191-9097
- OpenAlex
- W2557184343
- Semantic Scholar
- 2168d80c9acb8c364f8c3b161ffa7bc3704bab78
- Cited by
- 114
- References
- 141
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 6 · 2018: 4
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nanotechnology Reviews (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- nanoparticles, biofilm, biofilm-associated infections, chronic infection, antibiotic resistance, antibiofilm activity, biofilm eradication, nanoparticle characterization, nanotherapeutics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.